Initially, IFNγ/STAT1 signaling helps protecting the host from tumor formation and development (immune surveillance), but subsequently IFNγ can also promote the tumors to resist attack (immunoediting) and escape by Darwinian evolution [473, 497, 526]. The gene discussed is STAT1; the disease is neoplasm.